- Home
- DTI vs IKNA Comparison
DTI vs IKNA Comparison
Compare DTI & IKNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DTI
- IKNA
- Stock Information
- Founded
- DTI 1984
- IKNA 2016
- Country
- DTI United States
- IKNA United States
- Employees
- DTI 447
- IKNA N/A
- Industry
- DTI Metal Fabrications
- IKNA Biotechnology: Pharmaceutical Preparations
- Sector
- DTI Industrials
- IKNA Health Care
- Exchange
- DTI Nasdaq
- IKNA Nasdaq
- Market Cap
- DTI 68.0M
- IKNA 61.8M
- IPO Year
- DTI N/A
- IKNA 2021
- Fundamental
- Price
- DTI $1.88
- IKNA $1.11
- Analyst Decision
- DTI Strong Buy
- IKNA Buy
- Analyst Count
- DTI 1
- IKNA 2
- Target Price
- DTI $5.50
- IKNA $3.00
- AVG Volume (30 Days)
- DTI 114.2K
- IKNA 84.2K
- Earning Date
- DTI 05-08-2025
- IKNA 05-12-2025
- Dividend Yield
- DTI N/A
- IKNA N/A
- EPS Growth
- DTI N/A
- IKNA N/A
- EPS
- DTI 0.09
- IKNA N/A
- Revenue
- DTI $154,446,000.00
- IKNA N/A
- Revenue This Year
- DTI $12.21
- IKNA N/A
- Revenue Next Year
- DTI $6.26
- IKNA N/A
- P/E Ratio
- DTI $20.89
- IKNA N/A
- Revenue Growth
- DTI 1.59
- IKNA N/A
- 52 Week Low
- DTI $1.43
- IKNA $0.97
- 52 Week High
- DTI $6.36
- IKNA $1.94
- Technical
- Relative Strength Index (RSI)
- DTI 38.67
- IKNA 38.47
- Support Level
- DTI $1.75
- IKNA $1.06
- Resistance Level
- DTI $2.03
- IKNA $1.25
- Average True Range (ATR)
- DTI 0.29
- IKNA 0.10
- MACD
- DTI 0.00
- IKNA 0.00
- Stochastic Oscillator
- DTI 38.14
- IKNA 39.83
About DTI Drilling Tools International Corporation
Drilling Tools International Corp manufactures, rents, inspects, and refurbishes downhole drilling tools primarily to companies in the oil and natural gas industry for bottom hole assemblies used in onshore and offshore horizontal and directional drilling. The company's United States operations have locations in Texas, California, Louisiana, Oklahoma, Pennsylvania, North Dakota, New Mexico, Utah, and Wyoming. The company's single segment derives revenues from customers by providing oilfield equipment and services to operators in the oil and natural gas sectors.
About IKNA Ikena Oncology Inc.
Ikena Oncology Inc is a targeted oncology company developing precision therapies for patients in need that target nodes of cancer growth, spread, and therapeutic resistance in the Hippo and RAS onco-signaling network. Its targeted oncology product candidate, IK-930, is an oral small-molecule inhibitor of the transcriptional enhanced associate domain, or TEAD, a transcription factor in the Hippo signaling pathway, a known oncogenic pathway that also drives resistance to multiple targeted and chemotherapies. Its other product candidates are IK-175 and IK-595.